Tags |
|
|
Links |
|
|
Just Other Articles - Virtual Seminars - Do They Really Work?
Recently there was a week long Virtual Seminar on the web and as a mat
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ter of fact, it is still going on. You could attend and listen in for
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ays at a time or you could buy the information and download it later.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Both options seem excellent and the price tag is reasonable. The topic
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and speakers are top notch and probably people I would like to hear i
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
person. So, how popular are these virtual seminars?
The resu
The resu
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
lts are not yet in and I have only heard a few comments on the quality
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
of the information. Frankly, I like the way Fred Gleeck conducts his s
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
minars, he delivers a lot of information and huge value, even if the e
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
vent is free. However, most of the other speakers I have heard give li
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
tle information and want you to buy they expensive package. If the tru
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
h be known, if I get huge value out of the free or inexpensive seminar
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
, I am more likely to buy (way to go Fred!).
So far the jury
So far the jury
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
is out and since there are so many speakers on so many topics, I am do
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
bting the focus of the Virtual Seminar Week. There are also thousands
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
of dollars of products to buy. Hey, I thought the seminar was going to
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
give me good information I could use right away! I don't mind spending
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
a few bucks but I don't want to mortgage my house to buy overpriced in
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
formation.
If you have attended any of these sessions, send m
If you have attended any of these sessions, send m
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
a comment through ezinearticles.com, I really would like your opinion
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/2096/justotherarticles-Virtual-Seminars--Do-They-Really-Work.html">Virtual Seminars - Do They Really Work?</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/2096/justotherarticles-Virtual-Seminars--Do-They-Really-Work.html]Virtual Seminars - Do They Really Work?[/url]
Related Articles:
Instantly Accept Payments in Multiple Different Ways
Do I Really Need QuickBooks for My Start-Up Business? And, How the Heck Do I Figure Out Which One?
Bookmark it:
|